US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

208.89

-1.6400-0.78%

Volume:158.34K

Turnover:33.27M

Market Cap:10.60B

PE:33.09

High:211.73

Open:210.66

Low:208.89

Close:210.53

52wk High:217.12

52wk Low:144.65

Shares:50.75M

Float Shares:50.75M

Volume Ratio:0.59

T/O Rate:0.31%

Dividend:0.34

Dividend Rate:0.16%

EPS(TTM):6.31

EPS(LYR):35.34

ROE:24.54%

ROA:0.10%

PB:1.30

PE(LYR):5.91

Loading ...

Overview Company News Filings

Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing

Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Oscar Health (OSCR) and Argenx Se (ARGX)

Longeveron’s laromestrocel did not meet primary endpoint in Phase 2b HLHS trial

Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock

Affinor Growers Adds Biotechnology Innovator as Advisor to Bolster Vertical Farming Strategy

Exchange-Traded Funds Rise, US Equities Mixed After Midday

MT Newswires Live

Sector Update: Healthcare

MT Newswires Live

Sector Update: Healthcare

MT Newswires Live

Gilead - Expands Six Royalty-Free Voluntary Licensing Agreements for Once-Yearly Lenacapavir for Hiv Prevention

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)

The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.

Sling Therapeutics Raises $123 Million to Advance Thyroid Eye Disease Drug

Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers

Actinogen Medical Options Expire, Streamlining ASX-Listed Capital Structure

Cambium Bio Plans New Share Placement to Bolster Capital Base

Bristol Myers Sues Amgen over Proposed Opdivo Biosimilar

Sector Update: Healthcare

MT Newswires Live

ASX biotech expands diagnostics portfolio after FDA approval

Morning Star AU

Gilead Sciences Expands Lenacapavir Access to 14 Countries

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/IBB/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"iShares Biotechnology ETF","latestPrice":208.89,"timestamp":1790865665558,"preClose":210.53,"halted":0,"volume":158336,"delay":0,"changeRate":-0.007789863677385716,"floatShares":50750000,"shares":50750000,"eps":6.311863,"marketStatus":"Trading","change":-1.64,"latestTime":"10-01 10:41:11 EDT","open":210.66,"high":211.73,"low":208.89,"amount":33270980.59392,"amplitude":0.01349,"askPrice":208.93,"askSize":18,"bidPrice":208.82,"bidSize":130,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790884800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":210.53,"sharesOutstanding":49450000,"nav":211.023541,"aum":11226452381.2,"dividendRate":0.001614,"bidAskSpread":0.000363,"preHourTrading":{"tag":"盘前","latestPrice":210,"preClose":210.53,"latestTime":"09:27 EDT","volume":198,"amount":41672.93328,"timestamp":1790861278000,"change":-0.53,"changeRate":-0.002517,"amplitude":0.010126},"postHourTrading":{"tag":"盘后","latestPrice":210.53,"preClose":210.53,"latestTime":"19:40 EDT","volume":10410,"amount":2191616.46,"timestamp":1790811644228,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.591461,"impliedVol":0.2355,"impliedVolPercentile":0.49},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50750000,"roa":"0.10%","roe":"24.54%","lyrEps":35.344796,"volumeRatio":0.591461,"shares":50750000,"dividePrice":0.3371,"high":211.73,"amplitude":0.01349,"preClose":210.53,"low":208.89,"week52Low":144.65,"pbRate":"1.30","psRate":"255.06","week52High":217.12,"institutionHeld":0,"latestPrice":208.89,"committee":0.756757,"eps":6.311863,"divideRate":0.001614,"volume":158336,"delay":0,"ttmEps":6.311863,"open":210.66,"prevYearClose":168.77,"prevWeekClose":209.77,"prevMonthClose":210.53,"prevQuarterClose":210.53,"fiveDayClose":209.25,"twentyDayClose":213.8,"sixtyDayClose":196.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"IBB","amount":0.011194,"announcedDate":"2026-09-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-18"},{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"},{"executeDate":"2018-06-26","recordDate":"2018-06-27","paymentDate":"2018-07-02","value":0.15606,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668963550","title":"Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963550","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668963550?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:31","pubTimestamp":1789637460,"startTime":"0","endTime":"0","summary":"KUALA LUMPUR, Malaysia--Malaysian copper-composite manufacturer Vertex Material plans to go public in the U.S. next year after achieving a reported valuation of about $7 billion.The advanced-materials","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2462157665.USD","IDNA","VERX","LU1093756325.SGD","TBXU","LU2362541513.USD","MHGmain","ICOP","LU0432979614.USD","IE0002270589.USD","IE00B2B36J28.USD","COPP","IBB","BK4532","LU2468319806.SGD","UYM","LU0256863811.USD","LU1093756168.USD","LU1035775433.USD","LU2089984988.USD","XME","IE00BFTCPJ56.SGD","LU1069344957.HKD","LU0566484027.USD","IE0009355771.USD","LU0823416689.USD","PBE","BK4023","BBH","GNMX","IE00B894F039.SGD","IE00B19Z9Z06.USD","LU2324357040.USD","LU2236285917.USD","LU0889565916.HKD","COPJ","LU1430594728.SGD","VRTX","CPXR","QCmain","CPER","SG9999013999.USD","LU0320765992.SGD","BK4139","IE00B19Z9P08.USD","IBBQ","BIB","LU2237438978.USD","LU1778281490.HKD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963474","title":"Bayer receives FDA approval for Kerendia for CKD with type 1 diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963474","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668963474?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:30","pubTimestamp":1789637420,"startTime":"0","endTime":"0","summary":"Bayer (BAYRY) announced that theFDA approved Kerendia to reduce urinary albumin-to-creatinine ratio, which is expected to reduce the risk of sustai...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bayer-receives-fda-approval-for-kerendia-for-ckd-with-type-1-diabetes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bayer-receives-fda-approval-for-kerendia-for-ckd-with-type-1-diabetes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","LABU","NVIB","IDNA","LFSC","MEDI","MRNY","GNMX","RSPH","IEIH","FRTY","MRNX","GDOC","TBXU","XLVX","BBP","BK4588","PSCH","PINK","SYNB","BAYRY","IYH","BK4585","BMED","TECB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668405963","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Oscar Health (OSCR) and Argenx Se (ARGX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668405963","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668405963?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:30","pubTimestamp":1789637410,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Oscar Health (OSCR) and Argenx Se (ARGX). Oscar He...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-oscar-health-oscr-and-argenx-se-argx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-oscar-health-oscr-and-argenx-se-argx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","BK4162","IE0009355771.USD","LU0889565916.HKD","BK4139","IE00BFTCPJ56.SGD","LU0390134368.USD","LU2324357040.USD","BK4505","TBXU","IE0034235188.USD","OSCG","FMED","IE0002141913.USD","IE00BJJMRZ35.SGD","OSCR","BK4551","LU0823416689.USD","BK4588","IE00BJT1NW94.SGD","LU0109394709.USD","HEAL","LU1983260115.SGD","BK4585","IE00B2B36J28.USD","IE00B4R5TH58.HKD","ARGX","LU0320765992.SGD","OSCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668936994","title":"Longeveron’s laromestrocel did not meet primary endpoint in Phase 2b HLHS trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2668936994","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668936994?lang=en_us&edition=fundamental","pubTime":"2026-09-17 05:35","pubTimestamp":1789594520,"startTime":"0","endTime":"0","summary":"Longeveron (LGVN) announced topline results from ELPIS II, its Phase 2b clinical trial evaluating its investigational stem cell therapy laromestroc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/longeverons-laromestrocel-did-not-meet-primary-endpoint-in-phase-2b-hlhs-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/longeverons-laromestrocel-did-not-meet-primary-endpoint-in-phase-2b-hlhs-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","FBT","IDNA","BK4588","GDOC","TBXU","LGVN","CNCR","BK4585","GNOM","LFSC","MEDX","NVIB","SYNB","HYLG","BK4139","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668593306","title":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2668593306","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668593306?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:28","pubTimestamp":1789590524,"startTime":"0","endTime":"0","summary":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier sells USD 431,819 of common stockGilead: Chief Comm & Corp Aff Officer Johanna Mercier sold 3,000 common shares on Sep. 15, 20","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL6sfPNq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Chief Communications and Corporate Affairs Officer Johanna Mercier Sells USD 431,819 of Common Stock","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4578","LU0122379950.USD","LU0114720955.EUR","LU1674673691.USD","BIB","SG9999015952.SGD","LU0320765992.SGD","LU0859254822.USD","TMED","BK4568","LU2468319806.SGD","LU1023059063.AUD","IE00B19Z3581.USD","BBH","LU0109394709.USD","LU1585245621.USD","LU2089984988.USD","LU0289739699.SGD","LU1057294990.SGD","BK4566","MEDI","LU0823416689.USD","LU1430594728.SGD","LU0965509101.SGD","IE00B19Z3B42.SGD","IE00B3T34201.USD","LU0882574055.USD","LU2357627491.SGD","IE00BZ1G4Q59.USD","SG9999015986.USD","GILD","IE00BKVL7J92.USD","LU1066053197.SGD","BK4585","LU0234570918.USD","LU1066051498.USD","IBB","BMED","LU2087621335.USD","SG9999015945.SGD","IE00BSNM7G36.USD","TBXU","LU0965509283.SGD","BK4550","BK4588","LU1778281490.HKD","IBBQ","IE0002270589.USD","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668933761","title":"Affinor Growers Adds Biotechnology Innovator as Advisor to Bolster Vertical Farming Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2668933761","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668933761?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:03","pubTimestamp":1789588997,"startTime":"0","endTime":"0","summary":"Affinor Growers ( ($TSE:AFI) ) has issued an update. Affinor Growers has appointed biotechnology and sustainable agriculture innovator Dr. Hyder Kh...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/affinor-growers-adds-biotechnology-innovator-as-advisor-to-bolster-vertical-farming-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/affinor-growers-adds-biotechnology-innovator-as-advisor-to-bolster-vertical-farming-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVEG","AGNG","KROP","DARP","IEIH","BBP","SDGS","PJBF","RSPH","BK4588","IBB","LNGR","SYNB","SDG","FTAG","FHLC","FWD","XT","JDOC","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668987624","title":"Exchange-Traded Funds Rise, US Equities Mixed After Midday","url":"https://stock-news.laohu8.com/highlight/detail?id=2668987624","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668987624?lang=en_us&edition=fundamental","pubTime":"2026-09-17 01:08","pubTimestamp":1789578527,"startTime":"0","endTime":"0","summary":"Broad Market IndicatorsBroad-market exchange-traded funds IWM and IVV were higher. Actively traded Invesco QQQ Trust (QQQ) added 0.8%.US equity indexes traded mixed ahead of a likely interest-rate inc","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ARKY","VHT.AU","VIS","SPXU","XLF","RTH",".SPX","IYW","IYJ","QQQM","BETH","XLY","EETH","BITO","FDN","VHT","QQQ","SSO","XLV","FAZ",".IXIC","ETH",".DJI","STCE","ONEQ","DDM","STT","XLI","IYK","GLD","XLP","FTEC","XRT","IYE","XLE","FAS","XSD","BETE","SLV","USO","VDC","SOXX","IBB","BTF","IYH","UGL","RTH.AU","XLK","UNG","IGM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668876229","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2668876229","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668876229?lang=en_us&edition=fundamental","pubTime":"2026-09-17 01:07","pubTimestamp":1789578466,"startTime":"0","endTime":"0","summary":"Healthcare stocks rose Wednesday afternoon, with the NYSE Healthcare Index increasing 0.3% and the State Street Health Care Select Sector SPDR ETF  adding 0.4%.The iShares Biotechnology ETF  rose 0.8%.In corporate news, Sanofi  said Wednesday it has opened the Charles Best Building flu vaccine manufacturing facility in the Sanofi Toronto campus that will make its Fluzone High-Dose influenza vaccine. Sanofi shares were up 1%.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","IE00BFXG1179.USD","BK4007","IBB","LABU","HCSG","LU0029874061.USD","BK4581","SNY","XBI","BK4585","LU0128526141.USD","XLV","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667985175","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2667985175","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667985175?lang=en_us&edition=fundamental","pubTime":"2026-09-16 21:02","pubTimestamp":1789563772,"startTime":"0","endTime":"0","summary":"Healthcare stocks were edging higher pre-bell Wednesday, with the State Street Health Care Select Sector SPDR ETF  up 0.2% and the iShares Biotechnology ETF  advancing by 0.9%.Twist Bioscience  stock was up more than 4% after the company said it has agreed to provide antibody characterization data services to Lilly TuneLab, an AI/ML drug discovery platform created by Eli Lilly .","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FHLC","LU2468319806.SGD","SG9999015986.USD","LU0823434583.USD","IE00B775H168.HKD","XBI","IXJ","AGNG","LU1712237335.SGD","SG9999015945.SGD","LU0345770308.USD","LU1691799644.USD","LU1057294990.SGD","SG9999015952.SGD","SG9999013999.USD","IE00B1XK9C88.USD","LU0061475181.USD","LU2211815571.USD","SGXZ81514606.USD","IE00BJJMRY28.SGD","LU1145028129.USD","LU1323610961.USD","IE00BK4W5M84.HKD","LU2112291526.USD","LU0106261372.USD","LU0256863811.USD","LU1917777945.USD","LU2462591350.SGD","LU2106854487.HKD","LU2471134879.HKD","LU1093756168.USD","BK4581","SG9999014880.SGD","LU1988902786.USD","LU0266013472.USD","LU2168564149.EUR","LU2265009873.SGD","LU0058720904.USD","LU0456855351.SGD","LU0316494557.USD","LU0256863902.USD","IE0009355771.USD","LU2237443465.HKD","LU2237443382.USD","HRTS","LU2213496289.HKD","IE00B7KXQ091.USD","LLYX","LU2237443978.SGD","LU1127390331.HKD","SG9999017495.SGD","IE0001KFT4U8.USD","LU0471298694.HKD","LU2471134952.CNY","LU0964807845.USD","ELIL","SG9999018857.SGD","LU2750360997.AUD","LU0289739699.SGD","LU2108987350.USD","SG9999001176.USD","LU1280957306.USD","LU0158827948.USD","LU0672654240.SGD","PPH","SG9999001176.SGD","XLV","LU0097036916.USD","IE00BFSS8Q28.SGD","LU1868836914.USD","LU2552382058.USD","IDNA","LU0238689110.USD","LU1720051108.HKD","SGXZ31699556.SGD","IBB","IE00BKPKM429.USD","LU0198837287.USD","GNOM","LU0353189680.USD","LU0354030438.USD","LU1551013425.SGD","BK4007","LU0889565916.HKD","IE00B4R5TH58.HKD","LU1069344957.HKD","IHE","LU2023250504.SGD","LU2471134523.USD","LU0786609619.USD","IE00BN29S564.USD","LU2750360641.GBP","LU1868836757.USD","LU0203201768.USD","LU0385154629.USD","LU2360106947.USD","LU2756315664.SGD","IE00BJJMRZ35.SGD","LU2089284900.SGD","LU0079474960.USD","LU2552382215.SGD","LU0158827781.USD","RXL","LU2552382132.HKD","LU0323591593.USD","LU1974910355.USD","BK4139","SG9999018865.SGD","TWST","LU2168564222.USD","LU1623119135.USD","BK4533","MEDX","LU0225283273.USD","GDOC","LU2089283258.USD","ILDR","LU1232071149.USD","LU1979441026.SGD","LU2063271972.USD","LU2746668974.SGD","LLII","LU1804176565.USD","LU0320765992.SGD","ARKG","LU0114720955.EUR","LU1814569148.SGD","IE00BFTCPJ56.SGD","LU0787776722.HKD","LU1291159041.SGD","IE00BK4W5L77.USD","LU1064131342.USD","LU2023251221.USD","OZEM","LU1023059063.AUD","LLYZ","CURE","LU1868836591.USD","LU2462157665.USD","LU2471134796.USD","LU1035775433.USD","LLY","LU1989771016.USD","LU2361044949.HKD","LU2361045086.USD","SG9999015978.USD","SGXZ51526630.SGD","LU2361044865.SGD","LU0471298777.SGD","SGXZ99366536.SGD","LU2491049909.HKD","LU2602419157.SGD","LU0320765059.SGD","LU1983299246.USD","LU1366192091.USD","BK4599","IE0005OL40V9.USD","LU0210536198.USD","IE0004445015.USD","IYH","LU2028103732.USD","LU0122379950.USD","LU2324357040.USD","LU1548497426.USD","LU0174119429.USD","LU0234572021.USD","LU0109394709.USD","IE00BJLML261.HKD","LU2168563687.JPY","LU0353189763.USD","IE00BJT1NW94.SGD","LU0882574139.USD","SGXZ57979304.SGD","LU2357305700.SGD","LU2237443622.USD","LU1061106388.HKD","BK4588","PJP","LU2756315318.SGD","LU0823416689.USD","TRUH","LU0820561818.USD","IE00BWXC8680.SGD","LU0354030511.USD","LU0432979614.USD","LU2456880835.USD","WDNA","BK4585","LU2237443895.HKD","JDOC","LU0094547139.USD","IE00BFSS7M15.SGD","LU0683600562.USD","BK4534","LU0823434740.USD","LU2237438978.USD","SG9999014914.USD","LU0640476718.USD","FTXH","LU2896262040.SGD","MEDI","VHT","IE00B1BXHZ80.USD","LU2264538146.SGD","LU1629891620.HKD","LU2271345857.HKD","LU2168564065.EUR","LU2461242641.AUD","LU0006306889.USD","IE0004445239.USD","LU0345770993.USD","THNR","LU0417517546.SGD","IE0002141913.USD","LU2236285917.USD","LU0466842654.USD","LU2237443549.SGD","ELIS","IE00B4JS1V06.HKD","LABU","LU1868837300.USD","LU0820561909.HKD","IE00B2B36J28.USD","LU0689472784.USD","LU2746668461.USD","TMED","LU1093756325.SGD","SG9999014898.SGD","LU2087625088.SGD","LU2089984988.USD","LU0203202063.USD","IE00BKDWB100.SGD","LU2491050071.SGD","GB00BDT5M118.USD","LU0708995401.HKD","LU2023250330.USD","LU2417539215.USD","LU0133085943.USD","CANC","LU0820562030.AUD","LU2111349929.HKD","BK4516","IE00BJJMRX11.SGD","LU1720051017.SGD","LU2491050154.USD","MHIP","LU1551013342.USD","SG9999014906.USD","LU1267930730.SGD","LU0109391861.USD","LU2168564495.EUR","LU0096364046.USD","LU1868837136.USD","LU0943347566.SGD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667983112","title":"Gilead - Expands Six Royalty-Free Voluntary Licensing Agreements for Once-Yearly Lenacapavir for Hiv Prevention","url":"https://stock-news.laohu8.com/highlight/detail?id=2667983112","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667983112?lang=en_us&edition=fundamental","pubTime":"2026-09-16 20:30","pubTimestamp":1789561801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nTUA4XXCG2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TMED","SG9999015945.SGD","LU0965509101.SGD","BIB","IE00B7SZLL34.SGD","LU1839511570.USD","LU0823416689.USD","BK4550","LU0882574055.USD","LU0114720955.EUR","LU0122379950.USD","LU0861579265.USD","TBXU","LU0234570918.USD","LU2089984988.USD","LU1430594728.SGD","BK4566","LU2112291526.USD","LU0058720904.USD","LU1585245621.USD","LU0965509283.SGD","LU1057294990.SGD","LU1066053197.SGD","BMED","BBH","LU1061106388.HKD","IE00BZ1G4Q59.USD","LU2324357040.USD","IBBQ","LU0965509010.AUD","BK4568","LU2087621335.USD","SG9999015978.USD","LU1037948897.HKD","LU0109394709.USD","MEDI","IE00B19Z3581.USD","IE00BKVL7J92.USD","LU2357627491.SGD","IBB","LU1037948541.HKD","LU1934455277.USD","LU0859254822.USD","GILD","LU1023059063.AUD","SG9999015952.SGD","LU1934455863.HKD","IE00BSNM7G36.USD","LU1571399168.USD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667979600","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667979600","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667979600?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:20","pubTimestamp":1789557614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-ascendis-pharma-asnd-and-charles-river-labs-crl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-ascendis-pharma-asnd-and-charles-river-labs-crl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERX","LU2362540622.SGD","BK4585","IE00BJJMRZ35.SGD","LU0390134368.USD","LU1093756168.USD","IBBQ","BK4581","BK4023","CRL","LU1093756325.SGD","XBI","LU1035775433.USD","LU0289739699.SGD","MEDI","PBE","LU2417539215.USD","LU0889565916.HKD","BK4588","GNMX","LU2236285917.USD","VRTX","LU1430594728.SGD","LU0757428866.USD","LU0061475181.USD","IBB","LU1559883803.SGD","LU1674673428.USD","LU2324357040.USD","IDNA","XLV","LU0109394709.USD","LABU","LU1585245621.USD","LU2237438978.USD","IE00BZ9MQY76.HKD","LU1778281490.HKD","HCSG","LU2362541273.HKD","LU2462157665.USD","SGXZ57979304.SGD","TBXU","ASND","BBH","IE00B894F039.SGD","LU1069344957.HKD","BIB","LU0029874061.USD","IE0009355771.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667600950","title":"The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.","url":"https://stock-news.laohu8.com/highlight/detail?id=2667600950","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667600950?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:20","pubTimestamp":1789557600,"startTime":"0","endTime":"0","summary":"T. Rowe Price manager looks for trouble to find his global value betsT.Rowe Price manager Sebastien Mallet is betting on more than technology for his five-star fund.One secret to global value manager Sebastien Mallet's success?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1699723380.USD","LU0048584097.USD","LU0823434583.USD","LU0823434740.USD","SKDD","LU1267930490.SGD","BIB","BK4142","LU2324357040.USD","JPM","IE00B1BXHZ80.USD","BK4581","IE00BQXX3D17.EUR","LU1430594728.SGD","SG9999004303.SGD","SIL","IE00B5TLWC47.USD","LU0353189763.USD","LU0109392836.USD","LU0964807845.USD","LU1861220033.SGD","LU2552382215.SGD","BK4573","LU1839511570.USD","IE00BKDWB100.SGD","BK4588","LU0859254822.USD","LU0320765646.SGD","LU2357627491.SGD","AMDS","WUGI","LU0612318971.USD","LU0210536198.USD","LU2106854487.HKD","GAMR","BK4007","LU0211331839.USD","UYG","LU1267930573.SGD","LU1778281490.HKD","LU0170899867.USD","LU1923623000.USD","LU1934455277.USD","LU2112291526.USD","SG9999002224.SGD","AWAY","IE00BJTD4N35.SGD","IE0034235188.USD","BK4543","LU2417539215.USD","LU1674673691.USD","IE00BWXC8680.SGD","LU2008162690.USD","LU0056508442.USD","CHPS","BK4529","LU1914381329.SGD","LU2237443895.HKD","LU0234570918.USD","SINTCmain","LU2756315318.SGD","ARTY","LU1116320737.USD","LU0496365809.HKD","LU2211815571.USD","LU0320765992.SGD","LU0345770993.USD","LU2750360641.GBP","AMDW","LU0965509283.SGD","BK4602","AIQ","LU0417517546.SGD","LU2237443465.HKD","LU1720051017.SGD","SG9999015952.SGD","LU2746668974.SGD","HYNX","LEGR","BK4534","IE00B5949003.HKD","LU0823421333.USD","SG9999002232.USD","07709","LU1261432733.SGD","BMED","LU0174119429.USD","IETC","LU2764263039.SGD","SOXY","LU0157215616.USD","LU0823411888.USD","SG9999015945.SGD","IE0034235295.USD","CHAT","BK4515","SMH","LU0251131958.USD","BK4561","AZNH","LU1861558580.USD","LU0882574139.USD","LU2471134952.CNY","LU0390134368.USD","AZN","LU0097036916.USD","LU0058720904.USD","LU2168563687.JPY","LU1951198990.SGD","LU0683600562.USD","LU2471134879.HKD","LU0077335932.USD","LU2461242641.AUD","LU2430703178.SGD","LU1066053197.SGD","BK4504","BK4139","AMDY","LU1236620834.HKD","LU0211327993.USD","FNCL","TRUF","IE00BJLML261.HKD","LU2361044865.SGD","IE000F7OJYX1.SGD","IE00BQXX3F31.USD","IE00BN8TJ469.HKD","SGXZ51526630.SGD","LU0823413587.USD","LU2237443549.SGD","LU0820561909.HKD","IE00B3T34201.USD","LU2430703095.HKD","LU0965509101.SGD","INTW","LU1585245621.USD","LU0122379950.USD","LU0820562030.AUD","LU0029864427.USD","LU1242518931.SGD","AIS","SKHYV","LU2168564222.USD","LU0792757196.USD","LU2237957902.USD","SLVR","LU0316494557.USD","LU0265550359.USD","LU1829250122.USD","SOXX","LU0215105999.USD","SG9999015986.USD","CNAV","FTXL","LU0345769128.USD","IE0009356076.USD","LU1852331112.SGD","LU0187121727.USD","IE00BQXX3C00.GBP","LU1989764748.USD","BK4548","IE00BLSP4452.SGD","INT","BK4578","BK4141","LU0234572021.USD","LU1670627923.USD","GDX","LU0868494617.USD","BK4535","BK4605","LU0149725797.USD","LU2168564149.EUR","LU2244417387.USD","LU1951200564.SGD","LU1303367103.USD","LU2430703251.USD","LU2242649171.HKD","LU1116320901.HKD","LU0256863902.USD","LU1551013425.SGD","LU2108987350.USD","LU2462157665.USD","IE000WAW04H5.SGD","DAMD","LU1061106388.HKD","LU2237443622.USD","SMHX","LU0127658192.USD","IE00BKVL7J92.USD","LU0128525929.USD","LU1974910355.USD","LU1150488218.USD","LU0106261372.USD","LU2764262908.HKD","IE000BZT7R73.USD","VFH","BK4232","SKHN","LU0979878070.USD","LU1934455863.HKD","TBXU","IE000SO60NU8.SGD","LU0203347892.USD","IE00BBT3K403.USD","LU0889566641.SGD","USXF","GOAU","LU1894683348.USD","SKHY","AMDU","BK4585","LU2357305700.SGD","LU0265550946.USD","LU0274383776.USD","LU2264538146.SGD","IE00BMPRXN33.USD","LU1934455194.USD","ILDR","BK4017","LU0211326755.USD","AMYY","LU1043141123.HKD","AMUU","LU0889565916.HKD","LU0432979614.USD","LU0868494708.USD","LU1803068979.SGD","LU1037948897.HKD","MEDI","IE00BHPRN162.USD","LU1988902786.USD","LU1236620750.USD","LU0823421416.USD","AMDG","LU0154236417.USD","WNDR","LU0133085943.USD","LU1043141396.HKD","IYF","SG9999015978.USD","LU1880398471.USD","IE00B775SV38.USD","SKHA","BK4567","LU0557290698.USD","LU2247934214.USD","IE00B3S45H60.SGD","BK4614","LU0965509010.AUD","LU1629891620.HKD","LU0251142724.SGD","LU2265009873.SGD","LU0256863811.USD","LU0082616367.USD","JPMO","SKHU","LU2750360997.AUD","FMTL","BAI","INTC","IYG","LU0642271901.SGD","LU1267930813.SGD","LU2764263203.CNY","BK4583","LU2361044949.HKD","LINT","LU0345774391.USD","IE00B19Z3B42.SGD","LU0114720955.EUR","SGXZ99366536.SGD","AMDL","LU2250418816.HKD","LU0640476718.USD","LU2097829019.USD","SKHL","IE00BK4W5M84.HKD","LU1057294990.SGD","LU0267386448.USD","BK4612","IE00BDCRKT87.USD","LU0708994859.HKD","SKUU","BK4554","IE0034235303.USD","KBWB","LU0048573561.USD","LU2756315664.SGD","LU2471134796.USD","LU0310800379.SGD","IE000M9KFDE8.USD","LU0654597011.USD","LU0426417589.USD","LU1363072403.SGD","TEK","IE00BJTD4V19.USD","LU2098885051.SGD","SILJ","LU0882574055.USD","HK0000304805.HKD","SK","LU2089984988.USD","SKHZ","LU2456880835.USD","LU2355687059.USD","LU1037948541.HKD","LU0787776722.HKD","LU1023059063.AUD","TTEQ","LU0109394709.USD","LU0345769631.USD","LU1430597077.USD","LU2087625088.SGD","LU1989772840.SGD","XLF","LU2896262040.SGD","INYY","IXG","HK0000304797.USD","LU2462591350.SGD","BKNU","LU0345770308.USD","LU1670628061.USD","BK4512","LU1366192091.USD","SGXZ81514606.USD","LU1150488135.SGD","LU1145028129.USD","LU0070302665.USD","LU2023250843.SGD","LU0612318385.USD","LU1861559042.SGD","LU2089985449.USD","IE00BZ1G4Q59.USD","SGXZ23171101.USD","AMD","JBHT","LU1551013342.USD","LU0943347566.SGD","LU0211328371.USD","GLDN","LU0719512351.SGD","LU0823413660.USD","LU0006306889.USD","PSI","LU0689472784.USD","FTXO","LU2468319806.SGD","LU2592432038.USD","LU0976567544.SGD","LU1244550221.USD","TMED","LU0321505868.SGD","SKHX","LU0345774631.USD","LU2720916845.USD","BK4022","LU1280957306.USD","LU2177674079.SGD","LU2236285917.USD","IE000MB6IJN5.SGD","LU2543165471.USD","LU0823397285.USD","IE00B1XK9C88.USD","IE00BK4W5L77.USD","LU1496350171.SGD","BK4516","QQQA","LU0208291251.USD","LU0081259029.USD","FNV","GILD","LU2360106780.USD","LU2360107168.USD","BK4568","LU2458330169.SGD","BK4520","WPM","LU1121112475.USD","BK4135","LU0353189680.USD","LU1668664300.SGD","LU1316542783.SGD","LU0861579265.USD","LU0994945656.USD","LU0323591593.USD","LU2746668461.USD","LU1861215975.USD","04335","LU2237443382.USD","LU0211326839.USD","LU1917777945.USD","LU2237957811.SGD","LU0786609619.USD","LU0965508806.USD","LU2361045086.USD","LU2148611432.USD","IE00B19Z3581.USD","LU2087621335.USD","IE0000B7K699.USD","LU1032466523.USD","LU2458330243.SGD","LU0251132253.USD","LU1244550494.USD","AMDD","IE00BSNM7G36.USD","WISE","TROW","BK4533","LU2168564065.EUR","LU0971096721.USD","LU2552382058.USD","LU0198837287.USD","LU0889565833.HKD","BK4579","LU2505996681.GBP","LU2168564495.EUR","XNTK","LU1571399168.USD","BK4527","LU1956131251.USD","LU0225283273.USD","LU2505996509.AUD","FAI","LU0742534661.SGD","LU1366333091.USD","LU2860962120.EUR","LU2471134523.USD","LU2213496289.HKD","LU1894683264.USD","LU2237443978.SGD","IE00BFXG1179.USD","LU1119994496.HKD","BK4550","LU1989764664.SGD","IE0002270589.USD","SAMD0main","LU0942090050.USD","LU1162221912.USD","SG9999001440.SGD","LU1720051108.HKD","AMDC","LU1880398554.USD","IE00BMPRXR70.SGD","IE00BMPRXQ63.HKD","LU0106831901.USD","LU1989772923.USD","IE00B7SZLL34.SGD","AUAU","LU2054465674.USD","LU0238689110.USD","LU1674673428.USD","LU0320765489.SGD","LU0820561818.USD","LU0310799852.SGD","TRFK","LU2552382132.HKD","LU2023250330.USD","LU2931357623.SGD","LU1496350502.SGD","BBH","JPO","BKNG","LU0289739699.SGD","LU1244550577.SGD","LU1548497426.USD","SKHQ","SG9999001424.SGD","LU2381873111.SGD","IE00BLSP4239.USD","IE0001KFT4U8.USD","IBBQ","LU1242518857.USD","LU0823416689.USD","LU1064131342.USD","LU1084165304.USD","LU1232071149.USD","LU2023250504.SGD","BK4575","IBB","LU0203345920.USD","BK4566","BK4207","LU0266013472.USD","LU1804176565.USD","LU2290526834.HKD","IE00BYXW3230.USD","LU0426412945.USD","LU0823397103.USD","IE00BDRTCR15.USD","DRIV","TFNS","BK4532","LU1066051498.USD","IE0004445239.USD","LU0321505439.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667607925","title":"Sling Therapeutics Raises $123 Million to Advance Thyroid Eye Disease Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2667607925","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667607925?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:00","pubTimestamp":1789556400,"startTime":"0","endTime":"0","summary":"Sling Therapeutics raises $123 million to advance thyroid eye disease drugSept 16 (Reuters)-Drug developer Sling Therapeutics said on Wednesday ithad raised $123 million to advance a late-stage trial ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nL4N457178:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","BK4533","PBE","IE00BFTCPJ56.SGD","LU0122379950.USD","LU2112291526.USD","BK4566","LU0289739699.SGD","VRDN","LU1571399168.USD","LU2468319806.SGD","LU2089984988.USD","LU0868494617.USD","LU0109394709.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU1057294990.SGD","SG9999001440.SGD","BK4585","IE0002141913.USD","LU1061106388.HKD","BK4139","IE00B4R5TH58.HKD","IE0009355771.USD","LU0320765992.SGD","BK4534","LU2242646821.SGD","LU0058720904.USD","LU0889565916.HKD","AMGN","BIB","IE00BJT1NW94.SGD","BK4599","BBH","BK4588","LU1983299246.USD","LU2242652126.USD","BK4581","LU1023059063.AUD","TBXU","IBBQ","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667832674","title":"Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers","url":"https://stock-news.laohu8.com/highlight/detail?id=2667832674","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667832674?lang=en_us&edition=fundamental","pubTime":"2026-09-16 11:47","pubTimestamp":1789530442,"startTime":"0","endTime":"0","summary":"Rohto starts Phase II trial of RE-01 cell therapy for refractory ischemic leg ulcersRohto began CDMO manufacturing for RE-01 cell therapy used in a Phase II investigator-led trial for refractory ische","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDLJMrSH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0234570918.USD","LU1778281490.HKD","BK4532","BK4568","LU1057294990.SGD","LU1839511570.USD","LU1934455277.USD","LU2087621335.USD","LU0889565916.HKD","LU1585245621.USD","BMED","LU0965509010.AUD","LU0965509283.SGD","BK4583","LU2468319806.SGD","LU2089984988.USD","LU0058720904.USD","SG9999015945.SGD","LU0861579265.USD","TMED","LU1066053197.SGD","LU1066051498.USD","BBH","SG9999015986.USD","IBB","IE00BKVL7J92.USD","BIB","LU2112291526.USD","IBBQ","LU1037948541.HKD","LU0289739699.SGD","IE00BZ1G4Q59.USD","LU1037948897.HKD","IE00B7SZLL34.SGD","LU1934455863.HKD","LU0823416689.USD","TBXU","LU1674673691.USD","LU1934455194.USD","MEDI","LU2357627491.SGD","LU1430594728.SGD","BK4578","SG9999015978.USD","BK4550","GILD","LU1061106388.HKD","LU0114720955.EUR","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667679025","title":"Actinogen Medical Options Expire, Streamlining ASX-Listed Capital Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2667679025","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667679025?lang=en_us&edition=fundamental","pubTime":"2026-09-16 10:57","pubTimestamp":1789527450,"startTime":"0","endTime":"0","summary":"The latest update is out from Actinogen Medical ( ($AU:ACW) ). Actinogen Medical Limited, an ASX-listed biotechnology company, has reported changes...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-options-expire-streamlining-asx-listed-capital-structure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-options-expire-streamlining-asx-listed-capital-structure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","XT","BBP","RSPH","FHLC","IEIH","BK4585","BK4588","FWD","IBB","DARP","AGNG","SYNB","JDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667676156","title":"Cambium Bio Plans New Share Placement to Bolster Capital Base","url":"https://stock-news.laohu8.com/highlight/detail?id=2667676156","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667676156?lang=en_us&edition=fundamental","pubTime":"2026-09-16 09:52","pubTimestamp":1789523532,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Regeneus Ltd. ( ($AU:CMB) ). Cambium Bio Limited, trading on the ASX under the ticker CMB, is a biotechnology c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cambium-bio-plans-new-share-placement-to-bolster-capital-base?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cambium-bio-plans-new-share-placement-to-bolster-capital-base?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNGR","SYNB","BK4588","XT","JDOC","BK4585","IBB","AGNG","FWD","RSPH","FHLC","BBP","IEIH","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667624218","title":"Bristol Myers Sues Amgen over Proposed Opdivo Biosimilar","url":"https://stock-news.laohu8.com/highlight/detail?id=2667624218","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667624218?lang=en_us&edition=fundamental","pubTime":"2026-09-16 04:25","pubTimestamp":1789503924,"startTime":"0","endTime":"0","summary":"UPDATE 1-Bristol Myers sues Amgen over proposed Opdivo biosimilarSept 15 (Reuters)-Bristol Myers SquibbBMY.Nand Ono Pharmaceutical4528.Thave sued AmgenAMGN.Oin Delaware federal court, seeking to block","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL6N457192:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0267386448.USD","IBB","LU1057294990.SGD","LU1571399168.USD","LU1670710588.SGD","PBE","LU2125154935.USD","LU0114720955.EUR","LU1670711123.USD","IE00B2B36J28.USD","LU2468319806.SGD","BK4007","LU0456855351.SGD","LU1236620750.USD","LU1868837300.USD","LU0320765992.SGD","LU1093756168.USD","BK4581","LU2125154778.USD","BK4534","LU1061106388.HKD","BK4533","LU0882574055.USD","LU1989771016.USD","LU1868836591.USD","LU0096364046.USD","AMGN","BK4532","LU1291159041.SGD","BMY","LU0321505868.SGD","LU0985481810.HKD","LU0061475181.USD","LU1868836757.USD","BK4588","LU0058720904.USD","LU0868494617.USD","LU2242646821.SGD","LU2596442595.SGD","IBBQ","LU0432979614.USD","BK4599","BK4139","LU0225284248.USD","BIB","LU1236620834.HKD","LU2133065610.SGD","LU1670710661.SGD","BBH","LU2360032135.SGD","BK4559","IE00BSNM7G36.USD","LU0306807586.USD","LU1261432733.SGD","LU0109394709.USD","LU1868836914.USD","LU2089984988.USD","SG9999001440.SGD","LU1430594728.SGD","LU2242652126.USD","BK4566","LU1074936037.SGD","LU1093756325.SGD","LU1023059063.AUD","LU0306806265.USD","LU1983299246.USD","LU0889565916.HKD","LU1883839398.USD","FTXH","LU2112291526.USD","BK4585","04332","LU1670711040.USD","LU1323610961.USD","IE0002141913.USD","IHE","IE00BJJMRZ35.SGD","LU0225771236.USD","IE00BFXG1179.USD","LU1585245621.USD","IE00BJT1NW94.SGD","LU1032466523.USD","LU0122379950.USD","TBXU","LU0237698245.USD","PJP","LU0289739699.SGD","LU0321505439.SGD","LU1718418525.SGD","IE0009355771.USD","IE00B4R5TH58.HKD","LU1868837136.USD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667629828","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2667629828","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667629828?lang=en_us&edition=fundamental","pubTime":"2026-09-16 01:05","pubTimestamp":1789491915,"startTime":"0","endTime":"0","summary":"Healthcare stocks were slightly higher Tuesday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF  each increasing about 0.1%.The iShares Biotechnology ETF  was down 1%.In corporate news, GSK  agreed to acquire global rights to an experimental T-cell engager therapy for multiple myeloma from Chinese biotechnology company Chimagen Biosciences in a deal worth up to $750 million, as the UK drugmaker aims to strengthen its blood cancer treatment portfolio. GSK shares were up 0.1%.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0029874061.USD","GSK.UK","IBB","XLV","HCSG","GSKH","BK4585","BK4137","BK4007","BK4588","GSK","LU1829250122.USD","BK4581","LABU","XBI","LU0128526141.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667671746","title":"ASX biotech expands diagnostics portfolio after FDA approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2667671746","media":"Morning Star AU","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667671746?lang=en_us&edition=fundamental","pubTime":"2026-09-16 00:00","pubTimestamp":1789488000,"startTime":"0","endTime":"0","summary":"Telix Pharmaceutical’s (ASX.TLX) Pixclara becomes the first positron emission tomography, or PET, imaging agent for glioma brain cancer to receive approval from the US Food and Drug Administration.Why","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.morningstar.com.au/stocks/asx-biotech-expands-diagnostics-portfolio-after-fda-approval","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"morningstar_stock","symbols":["BMED","TECB","MEDI","BK4585","MRNX","BBP","GNMX","GDOC","IEIH","NVIB","LFSC","TBXU","IBB","LABU","PINK","RSPH","IYH","XBIX","FRTY","XLVX","BK4588","IDNA","SYNB","MRNY","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667490625","title":"Gilead Sciences Expands Lenacapavir Access to 14 Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2667490625","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667490625?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:43","pubTimestamp":1789487029,"startTime":"0","endTime":"0","summary":"Gilead Sciences  said Tuesday it entered into an agreement with the Pan American Health Organization to expand access to twice-yearly lenacapavir as pre-exposure prophylaxis for HIV prevention.The agreement creates a new access pathway for 14 PAHO member states in Latin America and the Caribbean outside existing voluntary licensing agreements, complementing generic access efforts across the region, the company said.The countries are Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Mexico, Panama, Paraguay, Peru, Uruguay and Venezuela, Gilead said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBB","LU1023059063.AUD","SG9999015986.USD","TMED","LU0965509010.AUD","LU1571399168.USD","LU0861579265.USD","LU0234570918.USD","LU1037948541.HKD","LU0320765992.SGD","LU0058720904.USD","BK4550","MEDI","IE0002270589.USD","LU0882574055.USD","BBH","LU2112291526.USD","BK4568","IE00B7SZLL34.SGD","LU1037948897.HKD","LU0859254822.USD","LU1674673691.USD","LU2324357040.USD","LU0965508806.USD","LU0965509283.SGD","IE00BKVL7J92.USD","IE00B19Z3581.USD","LU1778281490.HKD","TBXU","IE00B3T34201.USD","BK4566","GILD","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","LU1839511570.USD","LU0823416689.USD","BK4588","SG9999015952.SGD","LU1430594728.SGD","LU0109394709.USD","BK4585","LU1061106388.HKD","LU1934455863.HKD","LU1674673428.USD","BMED","LU0114720955.EUR","BIB","LU0122379950.USD","IBBQ","LU1934455277.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}